BU Biolab Gets Approval for Research on Deadliest Pathogens

Original article from: Boston Globe posted on December 24, 2016. by Evan Allen & Felicia Gans

The Centers for Disease Control and Prevention has approved a Biosafety Level 4 laboratory to operate on Boston University’s medical campus in the South End, according to the Boston Public Health Commission.

Scientists in the National Emerging Infectious Diseases lab would have clearance to study the world’s deadliest pathogens, such as Ebola. The biolab still needs to win approval from the city’s health commission before that research can begin.

“It’s an important step; we’re excited that they have recognized the quality of our people and facilities, but we still need to wait on the rest of the process,” said Ronald B. Corley, the lab’s director.

The spread of Ebola and, more recently, the Zika virus, has shown how quickly pathogens can travel around the world, Corley said — and there are some we have not even discovered.

“This isn’t a closed circle. There are many pathogens out there that, as we encroach on the wilderness areas and forests, as we change the environment, we’re going to run into more and more,” Corley said. “Every little bit we learn helps us solve the problems for the next one.”

The Boston Public Health Commission said in a statement that it has been reviewing safety plans and procedures at the lab since 2013.

The commission “will continue to carry out a rigorous review process of National Emerging Infectious Diseases Laboratories’ application, including a review of safety and security protocols and an ongoing monitoring and inspection program to ensure that the Level 4 laboratory can operate safely prior to issuing any permits,” the commission said.

 

Read Full Article in Boston Globe